Improving Compliance to Iron and Folic Acid Supplementation Protocols: Experimental Evidence from Rural India
How to cite
Patel, Tirtha; Radhakrishnan, Diksha; Barnhardt, Sharon; Mamidi, Pavan. 2021. "Improving Compliance to Iron and Folic Acid Supplementation Protocols: Experimental Evidence from Rural India." AEA RCT Registry. AEARCTR-0007143. https://doi.org/10.1257/rct.7143-1.1
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
In this randomised controlled trial study, we will evaluate the impact of three communication-based interventions, delivered remotely, on improving the consumption of Iron and Folic Acid (IFA) supplements during pregnancy in rural India. Our interventions aim to make the risks of anemia for both mother and child salient, increase the value perception of IFA supplements amongst pregnant women, and support the habit formation of their daily consumption. We test for these interventions using two experiments; in the first, we randomize pregnant women with access to Whatsapp between control and a treatment, where the treatment group is given simplified counselling over the phone followed by some visual reinforcements over Whatsapp; in our second, we randomize pregnant women without access to Whatsapp between control and two treatments, where one treatment group is given simplified counselling over the phone followed by regular prescriptions of IFA tablets sent through SMS, and the second treatment group is sent catchy and tuneful IVRS reminders for regular tablet consumption. We deploy our experiments in rural Uttar Pradesh, with a sample of 1929 pregnant women.
Intervention
We have three interventions that we test in our two separate experiments:
(1) IVRS Reminders:
(a) Series of 13 behaviorally designed reminders using insights to grab attention and increase recall
(b) They were meant to invoke joy, humor, and excitement about the new baby while reminding individuals to consume IFA tablets daily for ensuring the baby’s health
(c) Delivered daily for the first 7 days and then every 2 days for the next 3 weeks
(2) Phone Counselling + SMS Prescription:
(a) Pregnant women were called on the phone (early morning or at night) and counseled on IFA and anemia
(b) The tone of the counseling was joyful and conveyed respect
(c) Script highlighted the risk of anemia
(d) Delivered 1 day after the pregnant women received phone counseling
(e) A prescription for IFA tablets with standard government-recommended dosage, along with instructions for avoiding side effects was sent to select pregnant women
(f) Personalized with the woman’s name and sent once every week for 4 weeks
(3) Phone Counselling + Whatsapp Visual Reinforcement
(a) Pregnant women were called on the phone (early morning or at night) and counseled on IFA and anemia
(b) The tone of the counseling was joyful and conveyed respect
(c) Script highlighted the risk of anemia
(d) Delivered 1 day after the pregnant women received phone counseling
(e) Smartphone users in this arm received visual information about risks to repeat the key framing
(f) Sent once every week for 4 weeks
Experimental design
Our research design is a straightforward randomised controlled field trial, where pregnant women between 4th to 8th month of the pregnancy are eligible for either the Feature Phone based experiment or the Smart Phone based experiment -- depending on whether they have access to WhatsApp.
1. Experiment 1a (Feature Phone Experiment): Participants were randomised between Control group, IVRS Reminders Treatment and Phone Counselling + SMS Prescription Treatment
2. Experiment 1b (Smart Phone Experiment): Participants were randomised between Control group, and Phone Counselling + Whatsapp Visual Reinforcement Treatment
Our treatments are bookended by a baseline and an endline, where we measure IFA tablet consumption and adherence practices, attitudes and intentions, along with standard demographics.
Design details
Cited by
No citation data available for this registration yet.